KEVIN CHARLES GORMAN - 21 May 2025 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Issuer symbol
NBIX
Transactions as of
21 May 2025
Transactions value $
$0
Form type
4
Filing time
22 May 2025, 17:29:54 UTC
Previous filing
14 Feb 2025
Next filing
29 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GORMAN KEVIN CHARLES Director 6027 EDGEWOOD BEND COURT, SAN DIEGO /s/ Darin Lippoldt, Attorney-in-Fact 22 May 2025 0001201096

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Non-Qualified Stock Option Award $0 +6.61K $0.00 6.61K 21 May 2025 Common Stock 6.61K $120.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests in 12 monthly installments beginning June 21, 2025.